ENTX
Entera Bio Ltd.
Company overview
- Market capitalization
- $132.42M
- Employees
- 20
- Latest publication
- 2026-09-29
About Entera Bio Ltd.
Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures. The company is also involved in the development of EB612, a tablet peptide replacement therapy, which is in Phase I clinical trial for the treatment of hypoparathyroidism; EB618, a GLP-1/glucagon dual agonist peptide, which is in Phase I clinical trial for the treatment of obesity, metabolic, and fibrotic disorders; and GLP-2 which is in Phase I clinical trial for the treatment of short bowel syndrome and disorders related to mucosal inflammation and nutrient malabsorption. It has a collaboration agreement with OPKO Biologics, Inc for the preclinical and clinical development of LA-PTH and oral dual agonist GLP-1/glucagon peptide. The company was incorporated in 2009 and is based in Jerusalem, Israel.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | — | 0USD | 0USD | 42,000USD | 181,000USD | 42,000USD |
| Cost Of Revenue | 0USD | 0USD | — | 0USD | 0USD | 42,000USD | — | 42,000USD |
| Gross Profit | 0USD | 0USD | — | 0USD | 0USD | 0USD | — | 0USD |
| Research Development | 3,201,000USD | 2,251,000USD | — | 1,643,000USD | 1,520,000USD | 1,123,000USD | 4,499,000USD | 1,477,000USD |
| Selling General Administrative | 124,000USD | 128,000USD | — | 122,000USD | 103,000USD | 1,440,000USD | — | 1,544,000USD |
| General And Administrative Expenses | 1,362,000USD | 1,288,000USD | — | 1,613,000USD | 1,148,000USD | 1,440,000USD | — | 1,544,000USD |
| Total Operating Expenses | 4,563,000USD | 3,539,000USD | — | 3,256,000USD | 2,668,000USD | 2,563,000USD | 9,594,000USD | 3,021,000USD |
| Operating Income | -4,563,000USD | -3,539,000USD | — | -3,256,000USD | -2,668,000USD | -2,563,000USD | — | -3,021,000USD |
| Total Other Income Expense Net | -2,749,000USD | 34,000USD | — | 56,000USD | 12,000USD | -4,000USD | — | 0USD |
| Labor And Related Expense | 484,000USD | 435,000USD | — | 418,000USD | 372,000USD | — | — | — |
| Net Income | -7,312,000USD | -3,505,000USD | -11,400,000USD | -3,200,000USD | -2,656,000USD | -2,567,000USD | 9,541,000USD | -3,021,000USD |
| Income Before Tax | — | — | — | — | — | — | — | -3,021,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | 0USD |
| Source | 0001178913-26-003947DeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosurePreliminary | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 42,000USD | 181,000USD | 14,000USD | 134,000USD | 571,000USD | 365,000USD | 236,000USD | 500,000USD |
| Cost Of Revenue | 42,000USD | 172,000USD | 56,000USD | 101,000USD | 373,000USD | 209,000USD | 448,000USD | 0USD |
| Gross Profit | 0USD | 9,000USD | -56,000USD | 33,000USD | 198,000USD | 156,000USD | -212,000USD | 500,000USD |
| Research Development | 6,004,000USD | 4,499,000USD | 4,454,000USD | 5,848,000USD | 6,771,000USD | 6,398,000USD | 6,961,000USD | 8,518,000USD |
| Selling General Administrative | 398,000USD | 5,095,000USD | 4,430,000USD | 7,253,000USD | 5,690,000USD | 4,891,000USD | 4,281,000USD | 2,843,000USD |
| General And Administrative Expenses | 5,525,000USD | 5,095,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 11,529,000USD | 9,594,000USD | 8,884,000USD | 13,050,000USD | 12,415,000USD | 11,289,000USD | 11,242,000USD | 11,361,000USD |
| Operating Income | -11,529,000USD | -9,585,000USD | -8,940,000USD | -13,017,000USD | -12,217,000USD | -11,133,000USD | -11,454,000USD | -10,861,000USD |
| Total Other Income Expense Net | 90,000USD | 58,000USD | 80,000USD | 83,000USD | -29,000USD | 1,170,000USD | 659,000USD | 557,000USD |
| Labor And Related Expense | 1,597,000USD | — | — | — | — | — | — | — |
| Income Before Tax | -11,439,000USD | -9,527,000USD | -8,860,000USD | -12,934,000USD | -12,246,000USD | -9,963,000USD | -10,795,000USD | -10,304,000USD |
| Income Tax Expense | 0USD | 14,000USD | 29,000USD | 137,000USD | -59,000USD | 20,000USD | 84,000USD | 557,000USD |
| Net Income | -11,439,000USD | -9,541,000USD | -8,889,000USD | -13,071,000USD | -12,187,000USD | -9,983,000USD | -10,795,000USD | -10,304,000USD |
| Net Interest Income | — | — | 50,000USD | 83,000USD | -29,000USD | -67,000USD | -84,000USD | 34,000USD |
| Tax Provision | — | — | -17,000USD | 137,000USD | -59,000USD | 20,000USD | — | — |
| Net Income From Continuing Ops | — | — | -9,929,000USD | -13,071,000USD | -12,187,000USD | -9,983,000USD | -10,795,000USD | -10,304,000USD |
| Ebit | — | — | -8,860,000USD | -13,017,000USD | -12,217,000USD | -11,133,000USD | -10,711,000USD | -10,861,000USD |
| Ebitda | — | — | -8,804,000USD | -12,953,000USD | -12,164,000USD | -10,908,000USD | -10,473,000USD | -10,807,000USD |
| Depreciation And Amortization | — | — | 56,000USD | 64,000USD | 53,000USD | 225,000USD | 238,000USD | 54,000USD |
| Reconciled Depreciation | — | — | 59,000USD | 64,000USD | 53,000USD | 225,000USD | 238,000USD | 54,000USD |
| Interest Expense | — | — | — | 26,002,000USD | 29,000USD | 1,395,000USD | 84,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -13,071,000USD | -12,187,000USD | -9,983,000USD | -10,795,000USD | -10,304,000USD |
| Interest Income | — | — | — | — | — | — | 743,000USD | 523,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 19,480,000USD | 13,129,000USD | 15,993,000USD | 17,407,000USD | 19,667,000USD | 21,600,000USD | 9,390,000USD | 7,741,000USD |
| Cash And Equivalents | 11,309,000USD | 4,137,000USD | 7,108,000USD | 8,574,000USD | 10,858,000USD | 12,573,000USD | 8,660,000USD | 6,915,000USD |
| Total Current Assets | 18,896,000USD | 12,493,000USD | 15,298,000USD | 17,007,000USD | 19,311,000USD | 21,218,000USD | 8,972,000USD | 7,340,000USD |
| Other Current Assets | 144,000USD | 256,000USD | 415,000USD | 262,000USD | 192,000USD | 165,000USD | 186,000USD | 89,000USD |
| Total Liabilities | 12,214,000USD | 2,442,000USD | 2,892,000USD | 2,173,000USD | 2,411,000USD | 2,221,000USD | 1,310,000USD | 1,289,000USD |
| Total Current Liabilities | 2,104,000USD | 1,576,000USD | 2,203,000USD | 1,571,000USD | 1,844,000USD | 1,623,000USD | 1,176,000USD | 1,111,000USD |
| Total Stockholder Equity | 7,266,000USD | 10,687,000USD | 13,101,000USD | 15,234,000USD | 17,256,000USD | 19,379,000USD | 8,080,000USD | 6,452,000USD |
| Total Equity Including Noncontrolling Interest | 7,266,000USD | 10,687,000USD | 13,101,000USD | 15,234,000USD | 17,256,000USD | 19,379,000USD | 8,080,000USD | 6,452,000USD |
| Property Plant Equipment Net | 483,000USD | 540,000USD | 599,000USD | 308,000USD | 269,000USD | 284,000USD | 332,000USD | 381,000USD |
| Accounts Payable | 575,000USD | 274,000USD | 448,000USD | 216,000USD | 383,000USD | 134,000USD | 132,000USD | 184,000USD |
| Short Term Debt | 199,000USD | 185,000USD | 230,000USD | 170,000USD | 194,000USD | 169,000USD | 170,000USD | 162,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -136,183,000USD | -128,871,000USD | -125,366,000USD | -122,350,000USD | -119,150,000USD | -116,494,000USD | -113,927,000USD | -111,569,000USD |
| Accumulated Other Comprehensive Income | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 41,000USD |
| Other Non Current Liabilities | — | — | 393,000USD | — | — | — | — | — |
| Net Receivables | — | — | 0USD | 0USD | 0USD | 126,000USD | 126,000USD | 42,000USD |
| Source | 0001178913-26-003947DeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 15,993,000USD | 9,390,000USD | 11,765,000USD | 13,127,000USD | 25,987,000USD | 9,722,000USD | 16,703,000USD | 13,341,000USD |
| Cash And Equivalents | 7,108,000USD | 8,660,000USD | — | — | — | — | — | — |
| Total Current Assets | 15,298,000USD | 8,972,000USD | 11,257,000USD | 12,849,000USD | 25,329,000USD | 9,109,000USD | 15,636,000USD | 12,466,000USD |
| Other Current Assets | 415,000USD | 186,000USD | 238,000USD | 294,000USD | 254,000USD | 261,000USD | 136,000USD | 220,000USD |
| Total Liabilities | 2,892,000USD | 1,310,000USD | — | — | — | — | — | — |
| Total Current Liabilities | 2,203,000USD | 1,176,000USD | 1,091,000USD | 1,341,000USD | 3,161,000USD | 1,841,000USD | 4,592,000USD | 1,788,000USD |
| Other Non Current Liabilities | 393,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 13,101,000USD | 8,080,000USD | 10,386,000USD | 11,754,000USD | 22,565,000USD | 7,510,000USD | 11,919,000USD | 10,116,000USD |
| Total Equity Including Noncontrolling Interest | 13,101,000USD | 8,080,000USD | — | — | — | — | — | — |
| Net Receivables | 0USD | 126,000USD | 0USD | 246,000USD | 183,000USD | 255,000USD | 278,000USD | 725,000USD |
| Property Plant Equipment Net | 599,000USD | 332,000USD | 488,000USD | 229,000USD | 395,000USD | 566,000USD | 462,000USD | 224,000USD |
| Accounts Payable | 448,000USD | 132,000USD | 83,000USD | 17,000USD | 166,000USD | 164,000USD | 334,000USD | 473,000USD |
| Short Term Debt | 230,000USD | 170,000USD | 134,000USD | 91,000USD | 179,000USD | 189,000USD | 177,000USD | — |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | — | — | — | 11,919,000USD | — |
| Retained Earnings | -125,366,000USD | -113,927,000USD | -104,386,000USD | -95,497,000USD | -82,426,000USD | -70,239,000USD | -62,912,000USD | -52,117,000USD |
| Accumulated Other Comprehensive Income | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 41,000USD | 8,965,000USD | 11,439,000USD | 13,060,000USD |
| Total Liab | — | — | 1,379,000USD | 1,373,000USD | 3,422,000USD | 2,212,000USD | 4,784,000USD | 3,225,000USD |
| Other Current Liab | — | — | 874,000USD | 1,233,000USD | 2,667,000USD | 1,330,000USD | 3,814,000USD | 1,090,000USD |
| Capital Stock | — | — | 1,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | — | 11,019,000USD | 12,309,000USD | 24,892,000USD | 8,593,000USD | 15,222,000USD | 7,506,000USD |
| Cash And Short Term Investments | — | — | 11,019,000USD | 12,309,000USD | 24,892,000USD | 8,593,000USD | 15,222,000USD | 11,521,000USD |
| Net Debt | — | — | -10,629,000USD | -12,218,000USD | -24,590,000USD | -8,161,000USD | -14,923,000USD | -7,506,000USD |
| Short Long Term Debt Total | — | — | 390,000USD | 91,000USD | 302,000USD | 432,000USD | 299,000USD | — |
| Property Plant Equipment Gross | — | — | 488,000USD | 229,000USD | 395,000USD | 548,000USD | 462,000USD | 224,000USD |
| Common Stock Shares Outstanding | — | — | 29,007,794shares | 28,808,090shares | 26,133,770shares | 18,417,093shares | 12,146,729shares | 11,510,150shares |
| Non Current Assets Total | — | — | 508,000USD | 278,000USD | 658,000USD | 612,999USD | 1,067,000USD | 875,000USD |
| Non Current Liabilities Total | — | — | 288,000USD | 32,000USD | 261,000USD | 371,000USD | 192,000USD | 1,437,000USD |
| Non Currrent Assets Other | — | — | 6,000USD | 6,000USD | 46,000USD | 46,999USD | -1,067,000USD | 651,000USD |
| Net Working Capital | — | — | 10,166,000USD | 11,508,000USD | 22,168,000USD | 5,836,000USD | 11,044,000USD | 10,678,000USD |
| Unclassified Equity | — | — | 114,729,000USD | 107,210,000USD | 104,950,000USD | 68,784,000USD | 51,473,000USD | 49,173,000USD |
| Other Liab | — | — | — | 32,000USD | 138,000USD | 81,000USD | 70,000USD | 65,000USD |
| Other Assets | — | — | — | 49,000USD | 263,000USD | 47,000USD | 865,000USD | — |
| Current Deferred Revenue | — | — | — | 43,000USD | 15,000USD | 158,000USD | 267,000USD | 225,000USD |
| Inventory | — | — | — | -294,000USD | — | -93,000USD | 76,000USD | 130,000USD |
| Net Tangible Assets | — | — | — | 11,754,000USD | 22,565,000USD | 6,060,000USD | 11,314,000USD | 9,465,000USD |
| Intangible Assets | — | — | — | — | — | 605,000USD | 605,000USD | 651,000USD |
| Short Term Investments | — | — | — | — | — | — | 0USD | 4,015,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 65,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 1,307,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|
| Depreciation | 16,000USD | 23,000USD | 15,000USD | 35,000USD |
| Stock Based Compensation | 1,296,000USD | 2,040,000USD | 1,113,000USD | 1,990,000USD |
| Other Non Cash Items | -2,755,000USD | — | — | — |
| Change To Account Receivables | 0USD | 126,000USD | 126,000USD | -42,000USD |
| Change To Liabilities | 110,000USD | 924,000USD | 1,168,000USD | -8,000USD |
| Change In Working Capital | 127,000USD | 210,000USD | 377,000USD | 59,000USD |
| Operating Cash Flow | -6,554,000USD | -5,537,000USD | -3,035,000USD | -5,351,000USD |
| Capital Expenditures | -3,000USD | -80,000USD | -37,000USD | 0USD |
| Investing Cash Flow | -3,000USD | -80,000USD | -37,000USD | 0USD |
| Financing Cash Flow | 10,089,000USD | 13,536,000USD | 13,286,000USD | 1,259,000USD |
| Effect Of Forex Changes On Cash | 21,000USD | 29,000USD | — | — |
| Change In Cash | 3,553,000USD | 7,948,000USD | 10,214,000USD | -4,092,000USD |
| End Cash Flow | 18,526,000USD | 16,688,000USD | 18,954,000USD | 6,993,000USD |
| Deferred Income Tax | — | — | — | 0USD |
| Source | 0001178913-26-003947DeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 7,000USD | 7,000USD | 8,000USD | 7,000USD | 8,000USD | 11,000USD | 11,000USD | 11,000USD |
| Stock Based Compensation | 672,000USD | 710,000USD | 927,000USD | 509,000USD | 604,000USD | 566,000USD | 928,000USD | 598,000USD |
| Change To Liabilities | -176,000USD | — | — | — | 888,000USD | — | — | — |
| Change In Working Capital | -174,000USD | 464,266USD | -178,096USD | 492,024USD | 2,000USD | 295,000USD | -76,000USD | 206,000USD |
| Operating Cash Flow | -3,090,000USD | — | — | — | -1,404,000USD | — | — | — |
| Capital Expenditures | 0USD | -29,836USD | -46,477USD | -29,176USD | -8,000USD | -3,000USD | -12,000USD | 0USD |
| Investing Cash Flow | 0USD | — | — | — | -8,000USD | — | — | — |
| Financing Cash Flow | 130,000USD | — | — | — | 13,337,000USD | — | — | — |
| Effect Of Forex Changes On Cash | 4,000USD | — | — | — | — | — | — | — |
| Change In Cash | -2,956,000USD | -1,719,000USD | -2,271,000USD | -1,700,000USD | 11,925,000USD | 1,747,000USD | -2,141,000USD | -119,000USD |
| End Cash Flow | 12,017,000USD | — | — | — | 20,665,000USD | — | — | — |
| Net Income | — | -3,016,000USD | -3,200,000USD | -2,656,000USD | — | -2,358,000USD | -3,021,000USD | -2,145,000USD |
| Other Non Cash Items | — | 517,690USD | 630,013USD | 511,342USD | — | 5,000USD | 4,000USD | -5,000USD |
| Change To Account Receivables | — | 1,888USD | 5,143USD | 126,000USD | — | -84,000USD | 15,000USD | -57,000USD |
| Total Cash From Operating Activities | — | -2,027,044USD | -2,740,082USD | -1,645,633USD | — | -1,467,000USD | -2,154,000USD | -1,335,000USD |
| Free Cash Flow | — | -2,056,880USD | -2,786,560USD | -1,674,810USD | — | -1,470,000USD | -2,154,000USD | -1,335,000USD |
| Total Cashflows From Investing Activities | — | -29,834USD | -46,472USD | -29,178USD | — | -3,000USD | — | — |
| Total Cash From Financing Activities | — | 387,362USD | 803,742USD | 13,058USD | — | 3,217,000USD | 13,000USD | 1,216,000USD |
| Issuance Of Capital Stock | — | 0USD | 71,000USD | 0USD | — | 3,359,000USD | -19,000USD | 601,000USD |
| Begin Period Cash Flow | — | 16,602,000USD | 18,873,000USD | 20,573,000USD | — | 6,993,000USD | 9,134,000USD | 9,253,000USD |
| End Period Cash Flow | — | 14,883,000USD | 16,602,000USD | 18,873,000USD | — | 8,740,000USD | 6,993,000USD | 9,134,000USD |
| Other Cashflows From Investing Activities | — | -2,836USD | — | — | — | — | -12,000USD | — |
| Other Cashflows From Financing Activities | — | 174,000USD | 250,000USD | -64,058USD | — | -142,000USD | -5,323USD | 596,000USD |
| Investments | — | — | -43,000USD | -29,000USD | — | -3,000USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 30,000USD | 46,000USD | 56,000USD | 64,000USD | 53,000USD | 63,000USD | 238,000USD | 54,000USD |
| Stock Based Compensation | 2,750,000USD | 2,556,000USD | 1,689,000USD | 2,247,000USD | 1,861,000USD | 901,000USD | 1,483,000USD | 1,233,000USD |
| Deferred Income Tax | 0USD | 14,000USD | — | — | — | — | — | — |
| Change To Account Receivables | 126,000USD | -126,000USD | 246,000USD | -63,000USD | 72,000USD | 23,000USD | 447,000USD | -725,000USD |
| Change To Liabilities | 1,360,000USD | 252,000USD | — | -164,000USD | -141,000USD | -279,000USD | -97,000USD | 102,000USD |
| Change In Working Capital | 442,000USD | -77,000USD | -195,000USD | -1,835,000USD | 1,409,000USD | -351,000USD | 691,000USD | -506,000USD |
| Operating Cash Flow | -7,370,000USD | -6,818,000USD | — | — | — | — | — | — |
| Capital Expenditures | -107,000USD | -3,000USD | -17,000USD | -46,999USD | -17,000USD | -53,000USD | -40,000USD | -68,000USD |
| Investing Cash Flow | -107,000USD | -3,000USD | — | — | — | — | — | — |
| Financing Cash Flow | 13,710,000USD | 4,476,000USD | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | -36,000USD | — | — | — | — | — | — | — |
| Change In Cash | 6,197,000USD | -2,345,000USD | -1,291,000USD | -12,583,000USD | 16,301,000USD | -6,559,000USD | 7,679,000USD | -4,240,000USD |
| End Cash Flow | 14,973,000USD | 8,740,000USD | — | — | — | — | — | — |
| Net Income | — | — | -8,889,000USD | -13,071,000USD | -12,187,000USD | -11,216,000USD | -10,795,000USD | -10,304,000USD |
| Other Non Cash Items | — | — | 1,489,000USD | -78,000USD | 18,000USD | 46,000USD | -569,000USD | -232,000USD |
| Total Cash From Operating Activities | — | — | -7,310,000USD | -12,499,000USD | -9,063,000USD | -10,557,000USD | -8,919,000USD | -9,796,000USD |
| Free Cash Flow | — | — | -7,327,000USD | -12,546,000USD | -9,080,000USD | -10,610,000USD | -8,959,000USD | -9,864,000USD |
| Investments | — | — | -15,000USD | -102,000USD | -17,000USD | -86,000USD | 3,946,000USD | -4,068,000USD |
| Total Cashflows From Investing Activities | — | — | -17,000USD | -102,000USD | -17,000USD | -53,000USD | 3,946,000USD | -4,068,000USD |
| Total Cash From Financing Activities | — | — | 6,036,000USD | 13,000USD | 25,381,000USD | 4,051,000USD | 12,652,000USD | 9,624,000USD |
| Issuance Of Capital Stock | — | — | 5,000USD | 5,000USD | 21,805,000USD | 3,985,000USD | 12,528,000USD | 9,624,000USD |
| Begin Period Cash Flow | — | — | 12,376,000USD | 24,892,000USD | 8,663,000USD | 15,222,000USD | 7,506,000USD | 11,746,000USD |
| End Period Cash Flow | — | — | 11,085,000USD | 12,309,000USD | 24,964,000USD | 8,663,000USD | 15,185,000USD | 7,506,000USD |
| Other Cashflows From Financing Activities | — | — | -580,000USD | 13,000USD | 3,576,000USD | 204,000USD | 238,000USD | -4,068,000USD |
| Unclassified Operating Cash Flow | — | — | -1,460,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 6,611,000USD | — | — | — | — | 4,182,000USD |
| Other Cashflows From Investing Activities | — | — | — | -55,000USD | -55,000USD | -33,000USD | 3,986,000USD | -4,000,000USD |
| Change To Inventory | — | — | — | — | -72,000USD | -95,000USD | 341,000USD | 117,000USD |
| Net Borrowings | — | — | — | — | — | -136,000USD | -114,000USD | -114,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 12,766,000USD | 9,624,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | -3,946,000USD | 4,068,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.